VEGFA and diabetes mellitus: In conclusion, these results suggested that mid-dose losartan administration may have a therapeutic effect by inhibiting apoptosis and regulating iNOS, eNOS, VEGF, and NF-κB protein expressions, which have been shown to play a role in the pathogenesis of DM-induced hepatic damage.